Literature DB >> 23727168

Pre-eclampsia and the risk of kidney disease.

Bjørn Egil Vikse1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23727168     DOI： 10.1016/S0140-6736(13)60741-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 2.  Angiogenic factors in preeclampsia: potential for diagnosis and treatment.

Authors:  Arvind Goel; Sarosh Rana
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

3.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

4.  Chronic kidney disease in preeclamptic patients: not found unless searched for-Is a nephrology evaluation useful after an episode of preeclampsia?

Authors:  Zineb Filali Khattabi; Marilisa Biolcati; Antioco Fois; Antoine Chatrenet; Delphine Laroche; Rossella Attini; Marie Therese Cheve; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2019-07-17       Impact factor: 3.902

5.  Is It Time to Utilize Genetic Testing for Living Kidney Donor Evaluation?

Authors:  Ekamol Tantisattamo; Uttam G Reddy; Hirohito Ichii; Antoney J Ferrey; Donald C Dafoe; Nick Ioannou; Jing Xie; Tessa R Pitman; Emily Hendricks; Natsuki Eguchi; Kamyar Kalantar-Zadeh
Journal:  Nephron       Date:  2021-12-09       Impact factor: 2.847

6.  Association of preeclampsia with podocyte turnover.

Authors:  Marlies E Penning; Kitty W M Bloemenkamp; Tom van der Zon; Malu Zandbergen; Joke M Schutte; Jan A Bruijn; Ingeborg M Bajema; Hans J Baelde
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

Review 7.  Low birth weight trends: possible impacts on the prevalences of hypertension and chronic kidney disease.

Authors:  Takeshi Kanda; Ayano Murai-Takeda; Hiroshi Kawabe; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2020-05-11       Impact factor: 3.872

8.  The Impact of Kidney Development on the Life Course: A Consensus Document for Action.

Authors: 
Journal:  Nephron       Date:  2017-03-21       Impact factor: 2.847

9.  A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group.

Authors:  Valerie A Luyckx; Norberto Perico; Marco Somaschini; Dario Manfellotto; Herbert Valensise; Irene Cetin; Umberto Simeoni; Karel Allegaert; Bjorn Egil Vikse; Eric A Steegers; Dwomoa Adu; Giovanni Montini; Giuseppe Remuzzi; Barry M Brenner
Journal:  Lancet       Date:  2017-03-09       Impact factor: 79.321

10.  Hypertensive disorders of pregnancy and the recent increase in obstetric acute renal failure in Canada: population based retrospective cohort study.

Authors:  Azar Mehrabadi; Shiliang Liu; Sharon Bartholomew; Jennifer A Hutcheon; Laura A Magee; Michael S Kramer; Robert M Liston; K S Joseph
Journal:  BMJ       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.